Max Taubert
Impact in
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy
- Pharmacogenetics and Drug Metabolism
-
- Pharmaceutical studies and practices
Papers in
- Pharmacology 15
- Antibiotics Pharmacokinetics and Efficacy 17
- Pharmacogenetics and Drug Metabolism 15
-
- Chronic Kidney Disease and Diabetes 7
- Acute Kidney Injury Research 2
- Co-authors
- Uwe Fuhr (33 shared papers)Michael Zöller (7 shared papers)Michael Vogeser (4 shared papers)Christina Scharf (4 shared papers)Sebastian Frechen (5 shared papers)Johannes Zander (5 shared papers)Martin H. J. Wiesen (4 shared papers)Xia Li (5 shared papers)
In The Last Decade
Max Taubert
39 papers receiving 555 citations
Peers
Comparison fields: 5 of 64
- Pharmacology 135
- Pharmacology 201
- Pediatrics, Perinatology and Child Health 49
- Molecular Medicine 22
- Nephrology 29
Countries citing papers authored by Max Taubert
This map shows the geographic impact of Max Taubert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Taubert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Taubert more than expected).
Fields of papers citing papers by Max Taubert
This network shows the impact of papers produced by Max Taubert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Taubert. The network helps show where Max Taubert may publish in the future.
Co-authors
The 25 scholars most cited alongside Max Taubert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 69 | |
| 2 | 2019 | 52 | |
| 3 | 2020 | 51 | |
| 4 | 2016 | 49 | |
| 5 | 2019 | 32 | |
| 6 | 2021 | 28 | |
| 7 | 2017 | 26 | |
| 8 | 2018 | 21 | |
| 9 | 2018 | 20 | |
| 10 | 2021 | 20 | |
| 11 | 2020 | 17 | |
| 12 | 2020 | 16 | |
| 13 | 2020 | 15 | |
| 14 | 2020 | 14 | |
| 15 | 2018 | 13 | |
| 16 | 2019 | 10 | |
| 17 | 2020 | 10 | |
| 18 | 2023 | 10 | |
| 19 | 2018 | 9 | |
| 20 | 2023 | 9 |
About Max Taubert
Max Taubert is a scholar working on Pharmacology, Pharmacology, Nephrology, Pediatrics, Perinatology and Child Health and Oncology, having authored 41 papers that have together received 561 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (17 papers), Pharmacogenetics and Drug Metabolism (15 papers), Chronic Kidney Disease and Diabetes (7 papers), Pharmaceutical studies and practices (7 papers), Drug Transport and Resistance Mechanisms (5 papers), Statistical Methods in Clinical Trials (3 papers), Atrial Fibrillation Management and Outcomes (2 papers) and Acute Kidney Injury Research (2 papers). The work is most often cited by research in Pharmacology (135 citations), Pharmacology (201 citations), Pediatrics, Perinatology and Child Health (49 citations), Molecular Medicine (22 citations) and Nephrology (29 citations). Max Taubert has collaborated with scholars based in Germany, China and Austria. Frequent co-authors include Uwe Fuhr, Michael Zöller, Michael Vogeser, Christina Scharf, Sebastian Frechen, Johannes Zander, Martin H. J. Wiesen, Xia Li, Lorenz Frey and Uwe Liebchen. Their work appears in journals such as European Journal of Clinical Pharmacology, Antimicrobial Agents and Chemotherapy, Clinical Pharmacology & Therapeutics, Scientific Reports and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.